Obesity is one of the most significant public health challenges in the United States. About 40% of American adults have obesity, and the rate has been climbing steadily for decades with no sign of leveling off. The problem extends beyond individual health: it strains the healthcare system, hits certain communities harder than others, and is projected to affect nearly half of all U.S. adults by 2030.
How Common Obesity Is Today
Between August 2021 and August 2023, 40.3% of U.S. adults had obesity, defined as a body mass index of 30 or higher. That number is roughly the same for men and women. What’s more alarming is severe obesity, with a BMI of 40 or above, which affects 9.4% of adults, with higher rates among women in every age group.
Children are following a similar trajectory. Among Americans aged 2 to 19, obesity prevalence rose from 13.9% in 1999-2000 to 21.1% by 2021-2023. Severe obesity in that same age group nearly doubled, climbing from 3.6% to 7.0%. These aren’t small shifts over a short window. They represent a generational trend that has been building for more than two decades.
Geographically, the burden isn’t distributed evenly. As of 2024, 17 states plus Puerto Rico and the U.S. Virgin Islands had adult obesity rates between 35% and 40%. Mississippi, West Virginia, and Guam exceeded 40%. No state has managed to push its rate below 20%.
Who Is Most Affected
Obesity does not affect all Americans equally. Black adults have the highest prevalence at 49.6%, followed by Hispanic adults at 44.8% and white adults at 42.2%. Asian adults have the lowest rate at 17.4%. The disparity is especially stark among women: 56.9% of Black women have obesity, compared with 43.7% of Hispanic women, 39.8% of white women, and 17.2% of Asian women.
Projections for 2030 suggest these gaps will widen. Severe obesity is expected to become the single most common weight category among Black adults (31.7%), low-income adults (31.7%), and women overall (27.6%). These disparities reflect differences in access to healthy food, safe places to exercise, healthcare quality, and the chronic stress that comes with economic insecurity.
The Health Consequences
Carrying significant excess weight raises the risk of nearly every major chronic disease. Among U.S. adults with obesity, 58% have high blood pressure and about 23% have diabetes. Both of those conditions are leading risk factors for heart disease, stroke, and kidney failure. Obesity also increases the likelihood of developing several types of cancer, sleep apnea, joint problems, and depression.
These aren’t distant risks. Many people develop high blood pressure and blood sugar problems in their 30s and 40s, decades earlier than previous generations. When obesity begins in childhood, as it now does for one in five American kids, the window for accumulating damage starts even sooner.
What It Costs the Country
The financial toll is enormous. The estimated annual medical cost of obesity in the U.S. was nearly $173 billion in 2019. On an individual level, people with obesity spend an average of $1,861 more per year on medical care than those at a normal weight. That gap adds up over a lifetime through more frequent doctor visits, more prescriptions, and higher rates of hospitalization and surgery.
These costs ripple outward. Employers absorb higher insurance premiums and lost productivity. Public insurance programs like Medicare and Medicaid bear a disproportionate share of obesity-related spending. And the figure will only grow: if current trends hold, with nearly half of adults projected to have obesity by 2030, healthcare budgets at every level will face increasing pressure.
Why It Keeps Getting Worse
No single factor explains the obesity crisis, but the American food environment plays an outsized role. More than half of the calories consumed by Americans, 55% on average, come from ultra-processed foods. These are products like packaged snacks, sugary drinks, frozen meals, and fast food that are engineered to be cheap, convenient, and easy to overeat. They tend to be calorie-dense but low in fiber and nutrients, which means your body gets energy without the signals that tell you to stop eating.
Physical activity has also declined, particularly in jobs. Most Americans now work in sedentary roles, and many communities are designed around cars rather than walking. Screen time has increased dramatically for both adults and children, displacing movement throughout the day. These environmental shifts are powerful because they don’t require any individual to make a bad decision. They simply make the default lifestyle one that promotes weight gain.
Stress, sleep deprivation, and certain medications also contribute. The body’s appetite and fat-storage systems respond to all of these inputs, and modern American life pushes most of them in the wrong direction simultaneously.
How Obesity Is Measured and Diagnosed
BMI remains the most widely used screening tool, but it has real limitations. In 2023, the American Medical Association adopted a policy acknowledging that while BMI correlates with body fat across large populations, it loses accuracy when applied to individuals. A muscular person and an inactive person of the same height and weight get the same BMI score, even though their health risks are very different.
The AMA now recommends using BMI alongside other measures like waist circumference, body composition, and metabolic markers such as blood sugar and cholesterol levels. This matters because it shifts the conversation from a single number on a scale to a fuller picture of someone’s actual health. It also means that insurance companies should not use BMI alone to deny coverage for treatment.
Treatment Is Changing Rapidly
For decades, the standard advice for obesity was diet and exercise, sometimes paired with behavioral counseling or bariatric surgery for severe cases. That landscape has shifted dramatically with the arrival of GLP-1 medications, a class of injectable drugs that reduce appetite and help the body regulate blood sugar. Originally developed for diabetes, these medications have proven remarkably effective for weight loss, with some patients losing 15% or more of their body weight.
In 2024, an estimated 6.9 million adults with diagnosed diabetes were using GLP-1 injectables, and demand for weight-loss prescriptions has surged far beyond the diabetes population. The medications are expensive, often exceeding $1,000 per month without insurance, and supply shortages have been common. Whether they can meaningfully bend the national obesity curve depends on how widely accessible and affordable they become over the next several years.
Even with new pharmaceutical options, the underlying environmental drivers remain. Medications help individuals, but they don’t change the food supply, the built environment, or the economic pressures that make obesity so persistent. Addressing the problem at a population level will require changes to all of these systems at once.